These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34564002)

  • 1. Longitudinal changes in energy cost during walking in boys with Duchenne Muscular Dystrophy (DMD).
    Sienko S; Buckon CE; Bagley A; Staudt L; Fowler E; Heberer K; Sison-Williamson M; McDonald C; Sussman MD
    Gait Posture; 2021 Oct; 90():301-306. PubMed ID: 34564002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-related longitudinal changes in metabolic energy expenditure during walking in boys with Duchenne muscular dystrophy.
    Brehm MA; Kempen JC; van der Kooi AJ; de Groot IJ; van den Bergen JC; Verschuuren JJ; Niks EH; Harlaar J
    PLoS One; 2014; 9(12):e115200. PubMed ID: 25506914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reliability of the walking energy cost test and the six-minute walk test in boys with Duchenne muscular dystrophy.
    Kempen JC; Harlaar J; van der Kooi AJ; de Groot IJ; van den Bergen JC; Niks EH; Verschuuren JJ; Brehm MA
    Neuromuscul Disord; 2014 Mar; 24(3):216-21. PubMed ID: 24365209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinematic changes in gait in boys with Duchenne Muscular Dystrophy: Utility of the Gait Deviation Index, the Gait Profile Score and the Gait Variable Scores.
    Sienko S; Buckon C; Bagley A; Fowler E; Heberer K; Staudt L; Sison-Williamson M; McDonald C; Sussman M
    Gait Posture; 2023 Feb; 100():157-164. PubMed ID: 36529026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the changes in the energy cost of walking between children with cerebral palsy and able-bodied peers over one year.
    Thomas SS; Buckon CE; Russman BS; Sussman MD; Aiona MD
    J Pediatr Rehabil Med; 2011; 4(3):225-33. PubMed ID: 22207099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Walking energy expenditure in able-bodied individuals: a comparison of common measures of energy efficiency.
    Thomas SS; Buckon CE; Schwartz MH; Sussman MD; Aiona MD
    Gait Posture; 2009 Jun; 29(4):592-6. PubMed ID: 19188067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Boys With Duchenne Muscular Dystrophy: 1-Year Locomotor Changes in Relation to a Control Group.
    Martini J; Caromano FA; Carvalho EV; Goya PA; Hayasaka RM; Nakazune S; Fávero FM; Voos MC
    Percept Mot Skills; 2018 Feb; 125(1):40-56. PubMed ID: 29171337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability and minimum detectable change for walking energy efficiency variables in children with cerebral palsy.
    Thomas SS; Buckon CE; Schwartz MH; Russman BS; Sussman MD; Aiona MD
    Dev Med Child Neurol; 2009 Aug; 51(8):615-21. PubMed ID: 19627334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Longitudinal Study of Quantitative Muscle Strength and Functional Motor Ability in Ambulatory Boys with Duchenne Muscular Dystrophy.
    Buckon CE; Sienko SE; Fowler EG; Bagley AM; Staudt LA; Sison-Williamson M; Heberer KR; McDonald CM; Sussman MD
    J Neuromuscul Dis; 2022; 9(2):321-334. PubMed ID: 34924398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of motor proficiency and functional ambulation in Duchenne muscular dystrophy with healthy peers.
    Yildiz S; Sahin S; Bulut N; Tunca Yilmaz O; Karaduman AA; Akel BS
    Somatosens Mot Res; 2020 Dec; 37(4):252-256. PubMed ID: 32583706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hip kinetics during gait are clinically meaningful outcomes in young boys with Duchenne muscular dystrophy.
    Heberer K; Fowler E; Staudt L; Sienko S; Buckon CE; Bagley A; Sison-Williamson M; McDonald CM; Sussman MD
    Gait Posture; 2016 Jul; 48():159-164. PubMed ID: 27267770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of gait in Duchenne Muscular Dystrophy: Relation of 3D gait analysis to clinical assessment.
    Romano A; Favetta M; Schirinzi T; Summa S; Minosse S; D'Amico A; Catteruccia M; Petrarca M; Castelli E; Bertini E; Vasco G
    Neuromuscul Disord; 2019 Dec; 29(12):920-929. PubMed ID: 31791868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gait deviations in Duchenne muscular dystrophy-Part 2. Statistical non-parametric mapping to analyze gait deviations in children with Duchenne muscular dystrophy.
    Goudriaan M; Van den Hauwe M; Simon-Martinez C; Huenaerts C; Molenaers G; Goemans N; Desloovere K
    Gait Posture; 2018 Jun; 63():159-164. PubMed ID: 29751322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Evaluation of Muscle Composition Using Magnetic Resonance in 4 Boys With Duchenne Muscular Dystrophy: Case Series.
    Senesac CR; Lott DJ; Forbes SC; Mathur S; Arpan I; Senesac ES; Walter GA; Vandenborne K
    Phys Ther; 2015 Jul; 95(7):978-88. PubMed ID: 25592189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Energy cost during walking in association with age and body height in children and young adults with cerebral palsy.
    Bolster EAM; Balemans ACJ; Brehm MA; Buizer AI; Dallmeijer AJ
    Gait Posture; 2017 May; 54():119-126. PubMed ID: 28288332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of muscle loss delay and improvement of hyperinsulinemia and insulin resistance in Duchenne muscular dystrophy supplemented with omega-3 fatty acids: A randomized study.
    Rodríguez-Cruz M; Atilano-Miguel S; Barbosa-Cortés L; Bernabé-García M; Almeida-Becerril T; Cárdenas-Conejo A; Del Rocío Cruz-Guzmán O; Maldonado-Hernández J
    Clin Nutr; 2019 Oct; 38(5):2087-2097. PubMed ID: 30420291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophy.
    Tian C; Wong BL; Hornung L; Khoury JC; Miller L; Bange J; Rybalsky I; Rutter MM
    Neuromuscul Disord; 2016 Nov; 26(11):760-767. PubMed ID: 27614576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural History of Steroid-Treated Young Boys With Duchenne Muscular Dystrophy Using the NSAA, 100m, and Timed Functional Tests.
    Miller NF; Alfano LN; Iammarino MA; Connolly AM; Moore-Clingenpeel M; Powers BR; Tsao CY; Waldrop MA; Flanigan KM; Mendell JR; Lowes LP
    Pediatr Neurol; 2020 Dec; 113():15-20. PubMed ID: 32979653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal community walking activity in Duchenne muscular dystrophy.
    Fowler EG; Staudt LA; Heberer KR; Sienko SE; Buckon CE; Bagley AM; Sussman MD; McDonald CM
    Muscle Nerve; 2018 Mar; 57(3):401-406. PubMed ID: 28692198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Alterations in Gait Features in Growing Children With Duchenne Muscular Dystrophy.
    Vandekerckhove I; Van den Hauwe M; De Beukelaer N; Stoop E; Goudriaan M; Delporte M; Molenberghs G; Van Campenhout A; De Waele L; Goemans N; De Groote F; Desloovere K
    Front Hum Neurosci; 2022; 16():861136. PubMed ID: 35721358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.